Table II.
DQB1*05:01 | DQB1*06:01 | DQB1*03:03 | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
SSc subsets | n (%) | p | OR (95% CI) | n (%) | p | OR (95% CI) | n (%) | p | OR (95% CI) |
dcSSc | 28 (14.3) | 0.048 | 2.03 | 17 (8.7) | 0.95 | 0.98 | 47 (24) | 0.177 | 0.72 |
IcSSc | 12 (7.6) | (0.95-4.4) | 14 (8.9) | (0.44-2.18) | 48 (30.4) | (0.44-1.19) | |||
| |||||||||
ATA (+) | 18 (10.7) | 0.74 | 0.9 | 21 (12.5) | 0.031 | 2.19 | 39 (23.2) | 0.26 | 0.77 |
ATA (-) | 25 (11.8) | (0.45-1.78) | 13.(6.1) | (1.01-4.79) | 60 (28.3) | (0.47-1.25) | |||
| |||||||||
ACA (+) | 12 (26.1) | 0.00067 | 3.6 | 5 (10.9) | 0.73 | 1.19 | 10 (21.7) | 0.386 | 0.72 |
ACA (-) | 25 (8.9) | (1.54-8.33) | 26 (9.3) | (0.38-3.51) | 78 (27.9) | (0.32-1.6) | |||
| |||||||||
anti-U1RNP (+) | 8 (11.8) | 0.87 | 1.07 | 3 (4.4) | 0.16 | 0.43 | 25 (36.8) | 0.02 | 1.93 |
anti-U1RNP (-) | 33 (11.1) | (0.43-2.57) | 29 (9.7) | (0.1-1.53) | 69 (23.2) | (0.06-3.51) | |||
| |||||||||
PF (+) | 30 (11.2) | 0.9 | 1.05 | 28 (10.5) | 0.052 | 3.15 | 63 (23.5) | 0.11 | 0.65 |
PF (-) | 9 (10.7) | (0.45-2.5) | 3 (3.6) | (0.88-13.4) | 27 (32.1) | (0.37-1.15) |
PF: pulmonary fibrosis